161 related articles for article (PubMed ID: 3025984)
21. Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects.
Boschetto P; Fabbri LM; Zocca E; Milani G; Pivirotto F; Dal Vecchio A; Plebani M; Mapp CE
J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):261-7. PubMed ID: 3040835
[TBL] [Abstract][Full Text] [Related]
22. Importance of airway inflammation for late asthmatic reactions induced by toluene diisocyanate in sensitized subjects.
Boschetto P; Zocca E; Bruchi O; Cappellazzo G; Milani GF; Pivirotto F; Mapp CE; Fabbri LM
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1080-4. PubMed ID: 2823559
[TBL] [Abstract][Full Text] [Related]
23. Chronic asthma due to toluene diisocyanate.
Moller DR; Brooks SM; McKay RT; Cassedy K; Kopp S; Bernstein IL
Chest; 1986 Oct; 90(4):494-9. PubMed ID: 3019611
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma.
Sastre J; Banks DE; Lopez M; Barkman HW; Salvaggio JE
J Allergy Clin Immunol; 1990 Mar; 85(3):567-72. PubMed ID: 2155957
[TBL] [Abstract][Full Text] [Related]
25. Absence of airway hyperreactivity to methacholine in a worker sensitized to toluene diisocyanate (TDI).
Smith AB; Brooks SM; Blanchard J; Bernstein IL; Gallagher J
J Occup Med; 1980 May; 22(5):327-31. PubMed ID: 6247471
[TBL] [Abstract][Full Text] [Related]
26. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma.
Saetta M; Maestrelli P; Di Stefano A; De Marzo N; Milani GF; Pivirotto F; Mapp CE; Fabbri LM
Am Rev Respir Dis; 1992 Jan; 145(1):169-74. PubMed ID: 1309964
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of toluene diisocyanate-induced asthma.
Padoan M; Pozzato V; Simoni M; Zedda L; Milan G; Bononi I; Piola C; Maestrelli P; Boschetto P; Mapp CE
Eur Respir J; 2003 Apr; 21(4):637-40. PubMed ID: 12762349
[TBL] [Abstract][Full Text] [Related]
28. Experiences of specific IgE in asthma due to diisocyanates.
Keskinen H; Tupasela O; Tiikkainen U; Nordman H
Clin Allergy; 1988 Nov; 18(6):597-604. PubMed ID: 2854010
[TBL] [Abstract][Full Text] [Related]
29. Occupational type test for the etiological diagnosis of asthma due to toluene di-isocyanate.
Zedda S; Cirla A; Aresini G; Sala C
Respiration; 1976; 33(1):14-21. PubMed ID: 173001
[TBL] [Abstract][Full Text] [Related]
30. Toluene diisocyanate-induced asthma: clinical findings and bronchial responsiveness studies in 113 exposed subjects with work-related respiratory symptoms.
Moscato G; Dellabianca A; Vinci G; Candura SM; Bossi MC
J Occup Med; 1991 Jun; 33(6):720-5. PubMed ID: 1650820
[TBL] [Abstract][Full Text] [Related]
31. [Occupational toluene diisocyanate (TDI) asthma--inhalation challenge test and TDI-HSA (human serum albumin) skin test and detection of specific IgE].
Duan YY
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Jun; 12(3):149-52, 191. PubMed ID: 2553281
[TBL] [Abstract][Full Text] [Related]
32. Occupational asthma without bronchial hyperresponsiveness.
Hargreave FE; Ramsdale EH; Pugsley SO
Am Rev Respir Dis; 1984 Sep; 130(3):513-5. PubMed ID: 6089628
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
Park HS; Nahm DH
Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
[TBL] [Abstract][Full Text] [Related]
34. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge.
Sastre J; Fernández-Nieto M; Novalbos A; De Las Heras M; Cuesta J; Quirce S
Chest; 2003 Apr; 123(4):1276-9. PubMed ID: 12684321
[TBL] [Abstract][Full Text] [Related]
35. Specific bronchial provocation tests in occupational asthma and methods of stimulation: case report.
Moscato G; Biscaldi G; Cottica D; Candura F
G Ital Med Lav; 1983 Nov; 5(6):259-61. PubMed ID: 6100489
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates.
Mapp CE; Boschetto P; Zocca E; Milani GF; Pivirotto F; Tegazzin V; Fabbri LM
Bull Eur Physiopathol Respir; 1987; 23(6):583-6. PubMed ID: 2840139
[TBL] [Abstract][Full Text] [Related]
37. Atropine does not inhibit late asthmatic responses induced by toluene-diisocyanate in sensitized subjects.
Paggiaro P; Bacci E; Talini D; Dente FL; Rossi O; Pulerá N; Fabbri LM; Giuntini C
Am Rev Respir Dis; 1987 Nov; 136(5):1237-41. PubMed ID: 2823652
[TBL] [Abstract][Full Text] [Related]
38. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study.
Kopferschmitt-Kubler MC; Frossard N; Rohde G; Pauli G
Respir Med; 1998 Sep; 92(9):1093-8. PubMed ID: 9926161
[TBL] [Abstract][Full Text] [Related]
39. Increased neutrophil leukocyte chemotaxis induced by release of a serum factor in toluene-diisocyanate (TDI) asthma.
Valentino M; Governa M; Fiorini R
Lung; 1988; 166(6):317-25. PubMed ID: 2853258
[TBL] [Abstract][Full Text] [Related]
40. Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI).
Paggiaro PL; Loi AM; Rossi O; Ferrante B; Pardi F; Roselli MG; Baschieri L
Clin Allergy; 1984 Sep; 14(5):463-9. PubMed ID: 6091946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
